Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ASTRAZENECA PLC Hits Price Target Forecast with 13.12% Profit

September 03, 2025
On July 31, 2025, QuantWave, an automated forecasting platform, issued a long signal for ASTRAZENECA PLC when the stock was trading at $72.59. The platform predicted a positive movement, and on September 3, 2025, the stock reached the forecasted target price of $82.11, resulting in a profit of 13.12% for investors who followed the recommendation.

The successful achievement of the price target highlights the accuracy and effectiveness of QuantWave's analytics in predicting stock movements. The platform's ability to provide timely and reliable forecasts gives investors valuable insights for making informed trading decisions.

Several factors may have contributed to ASTRAZENECA PLC's price increase, including strong performance in its pharmaceutical business, successful drug launches, and positive market sentiment towards the healthcare sector. Additionally, the company's efforts in research and development, strategic partnerships, and expanding market presence likely played a role in driving investor confidence and pushing the stock price higher.

QuantWave's accomplishment in accurately forecasting ASTRAZENECA PLC's price target showcases the platform's capability to deliver actionable insights and generate profitable trading opportunities for users. Investors can leverage QuantWave's predictive analytics to enhance their decision-making process and potentially achieve significant returns in the financial markets.

For those interested in exploring QuantWave's forecasting capabilities further, the platform offers predictions for a wide range of stocks, presenting opportunities for potential profits. Additionally, investors looking to deepen their understanding of the investment strategy behind QuantWave can benefit from the educational resources provided by QuantSchool. QuantSchool offers a comprehensive professional investment framework that reveals the key principles for generating consistent income using the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for AZN

Related data

AZNSeptember 3, 2025ASTRAZENECA PLC Hits QuantWave Forecast, Generating 16.24% Profit  ~2 min.

ASTRAZENECA PLC has successfully reached the price target forecasted by QuantWave on July 11, 2025. The forecast indicated a long position with a price of 70.64 $....


AZNSeptember 3, 2025ASTRAZENECA PLC Hits 11.81% Profit Target as Forecasted by QuantWave  ~1 min.

ASTRAZENECA PLC's stock has successfully reached the price target forecasted by QuantWave, resulting in a profit of 11.81%. The forecast signal was given on 2025-08-01 when the stock was trading at 73....


AZNSeptember 3, 2025ASTRAZENECA PLC Stock Hits QuantWave Price Target with Profit of 19.38%  ~1 min.

On July 17, 2025, QuantWave, the automated forecasting platform, issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.78 $....


AZNSeptember 3, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 17.98% Profit  ~1 min.

On July 16, 2025, QuantWave's automated forecasting platform issued a signal for ASTRAZENECA PLC, predicting a long position with the stock trading at $69.6....


AZNSeptember 3, 2025ASTRAZENECA PLC Hits QuantWave Forecast Target with 11.64% Profit  ~2 min.

ASTRAZENECA PLC has successfully reached the price target forecasted by QuantWave, resulting in a profit of 11.64%. The forecast signal was issued on August 8, 2025, with the stock priced at $73....


AZNSeptember 3, 2025ASTRAZENECA PLC Stock Hits Price Target with 12.34% Profit: QuantWave Forecast Success  ~1 min.

ASTRAZENECA PLC stock has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 12.34%. The forecast signal was generated on August 6, 2025, with a price of $73....


AZNAugust 25, 2025AstraZeneca's Breakthrough Study on Advanced Biliary Tract Cancer  ~1 min.

AstraZeneca PLC has recently announced groundbreaking results from their new study on advanced biliary tract cancer, showing promising potential for a new treatment option in cancer care....


AZNAugust 22, 2025ASTRAZENECA PLC Hits Price Target Forecast with 20.55% Profit  ~1 min.

On January 23, 2025, QuantWave issued a long signal for ASTRAZENECA PLC with a price of 67.17 $. The forecast proved to be accurate as the stock reached the target price of 80....


AZNAugust 22, 2025ASTRAZENECA PLC Stock Hits QuantWave's Price Target Forecast with 14.63% Profit  ~1 min.

ASTRAZENECA PLC stock has successfully reached the price target forecast provided by QuantWave, resulting in a profitable outcome for investors....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Price Target, Yielding 14.58% Profit - QuantWave Prediction Success  ~2 min.

On June 18, 2025, QuantWave issued a long forecast signal for ASTRAZENECA PLC when the stock was trading at $70.27....


AZNApril 25, 2024ASTRAZENECA PLC Hits Price Target Forecast with 13.92% Profit Margin  ~1 min.

On March 19, 2024, QuantWave's forecast signal for ASTRAZENECA PLC indicated a long position at a price of $64.09. The prediction proved to be accurate as the stock reached the target price of $73....


AZNDecember 9, 2024Is AstraZeneca PLC AZN the Most Profitable Pharmaceutical Stock Right Now?  ~2 min.

AstraZeneca PLC (AZN) is emerging as one of the most profitable pharmaceutical stocks in the market....


AZNDecember 1, 2024Why AstraZeneca PLC AZN is Gaining Momentum in the Pharmaceutical Industry  ~2 min.

AstraZeneca PLC (AZN) has been making headlines in the pharmaceutical industry due to its promising prospects and investment potential....


AZNDecember 7, 2024Why AstraZeneca PLC AZN is Revolutionizing the Pharmaceutical Industry  ~2 min.

AstraZeneca PLC AZN, a leading multinational pharmaceutical company, is making groundbreaking strides in the industry....


AZNDecember 4, 2024AstraZeneca PLC - A Promising Investment Opportunity for ADR Stocks  ~2 min.

AstraZeneca PLC (AZN) is making waves in the pharmaceutical industry with its groundbreaking research and innovative drug development....